The healthcare costs of antimicrobial resistance in Lebanon: a multi-centre prospective cohort study from the payer perspective
03 May 2021
This is the first nationwide study that quantifies the healthcare costs of antimicrobial resistance in Lebanon. For cases with HAIs, matched cohort analysis showed more conservative estimates compared with post-HAIs method. The differences in estimates highlight the need for a unified methodology to estimate the burden of antimicrobial resistance in order to accurately advise health policy makers and prioritize resources expenditure.
Further reading: BMC Infectious Diseases
Author(s): Katia Iskandar, Christine Roques, Souheil Hallit, Rola Husni-Samaha, Natalia Dirani, Rana Rizk, Rachel Abdo, Yasmina Yared, Matta Matta, Inas Mostafa, Roula Matta, Pascale Salameh & Laurent Molinier
Effective Surveillance
OUR UNDERWRITERS
Unrestricted financial support kindly provided by
 |
Antimicrobial Resistance Fighter Coalition |
 |
CDD VAULT Complexity Simplified |
Technology Database
Display your AMR Technology, Product and Service
Suppliers and Users of Technologies, Products and Services benefit from CAPI.
CAPI (Continuous AMR Partnering Initiative) unites Suppliers and Users worldwide with the aim to add to the curbing of AMR.
